Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
2019 · The Lancet · 1,172 citations
https://doi.org/10.1016/s0140-6736(19)33041-7
M
Mandana Khalili
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
220
Papers
4.6K
Citations
34
h-index
87
i10-index
Mandana Khalili is an academic researcher from San Francisco General Hospital. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Hepatitis C virus research & Hepatitis B Virus Studies. The author has an h-index of 34, co-authored 187 publications.
ORCID: 0000-0001-9178-9139Papers by this author
worksFormal Patient Education Improves Patient Knowledge of Hepatitis C in Vulnerable Populations
2010 · Digestive Diseases and Sciences · 77 citations
https://doi.org/10.1007/s10620-010-1455-3
Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort
2024 · Annals of Internal Medicine · 41 citations
https://doi.org/10.7326/m24-0737
Assessment of HBV Preventive Services in a Medically Underserved Asian and Pacific Islander Population Using Provider and Patient Data
2014 · Journal of General Internal Medicine · 32 citations
https://doi.org/10.1007/s11606-014-3057-9
Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B
2022 · The American Journal of Gastroenterology · 18 citations
https://doi.org/10.14309/ajg.0000000000002125
The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints
2024 · The American Journal of Gastroenterology · 16 citations
https://doi.org/10.14309/ajg.0000000000002953
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat